Vertex Pharmaceuticals Shares (Basic) decreased by 0.4% to 255.6M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.9%, from 258M to 255.6M.
A decreasing trend typically signals an aggressive share buyback program, which can increase the value of remaining shares.
Weighted-average shares outstanding (basic) is the calculation of the total number of common shares held by the public d...
Used to evaluate the scale of a company's equity base relative to its market capitalization and peer group.
is_weighted_shares_basic| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 259M | 257.9M | 255.1M | 255.9M | 256.5M | 257.4M | 257.7M | 258M | 258.2M | 258.1M | 258M | 256.9M | 256.7M | 255.6M |
| QoQ Change | — | -0.4% | -1.1% | +0.3% | +0.2% | +0.4% | +0.1% | +0.1% | +0.1% | -0.0% | -0.0% | -0.4% | -0.1% | -0.4% |
| YoY Change | — | — | — | -1.2% | -0.5% | +0.9% | +0.7% | +0.6% | +0.3% | +0.2% | +0.0% | -0.5% | -0.5% | -0.9% |